Cleared Special

K231549 - Advantage Ultra System, Advantage Fit Ultra System, Lynx Ultra System (FDA 510(k) Clearance)

Jun 2023
Decision
30d
Days
Class 2
Risk

K231549 is an FDA 510(k) clearance for the Advantage Ultra System, Advantage Fit Ultra System, Lynx Ultra System. This device is classified as a Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator (Class II - Special Controls, product code OTN).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on June 29, 2023, 30 days after receiving the submission on May 30, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 878.3300. Surgical Treatment Of Female Stress Urinary Incontinence Due To Intrinsic Sphincter Deficiency (isd) And/or Urethral Hypermobility.

Submission Details

510(k) Number K231549 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2023
Decision Date June 29, 2023
Days to Decision 30 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code OTN — Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition Surgical Treatment Of Female Stress Urinary Incontinence Due To Intrinsic Sphincter Deficiency (isd) And/or Urethral Hypermobility